Comparison of invasive ICP measurements to Distortion Product Otoacoustic Emissions (DPOAE) in adults during infusion testing for INPH by unknown
ORAL PRESENTATION Open Access
Comparison of invasive ICP measurements to
Distortion Product Otoacoustic Emissions (DPOAE)
in adults during infusion testing for INPH
MA Williams1*, SE Voss2, NJ Horton3, J Malm4, A Eklund4
From Hydrocephalus 2015
Banff, Canada. 18-21 September 2015
Introduction
Noninvasive ICP measurements are needed for astronauts
at risk for the Visual Impairment/Intracranial Pressure
(VIIP) syndrome. We evaluated distortion product otoa-
coustic emissions (DPOAE) for potential use to monitor
ICP changes noninvasively.
Methods
Eight subjects, mean age 68.5±7.4 years (range 58-79 years),
undergoing lumbar CSF infusion testing (Likvor Celda,
Umeå, Sweden) for hydrocephalus had DPOAE measure-
ments made during ICP recording in the supine and
upright positions, and during the infusion testing at
6 different ICP levels. DPOAE were measured with the
HearID system (Mimosa Acoustics, Champaign, IL) at
13 log-spaced frequencies between 500 and 4000 Hz.
DPOAE magnitudes within 6 dB of the noise floor, due in
part to presbyacusis, were not analyzed, resulting in 5 of
13 frequencies with results that could be analyzed. Changes
in DPOAE magnitudes and angles from the upright posi-
tion were analyzed for these 5 frequencies at 7 ICP levels.
For the DPOAE magnitudes and angles at each ICP and
frequency, a 95% confidence interval was calculated using a
bootstrap method. A statistically significant difference is
present when the confidence interval does not contain
zero.
Results
In general, increasing ICP resulted in decreasing DPOAE
magnitude and increasing DPOAE angle at all frequen-
cies. DPOAE angles show statistically significant changes
with ICP for all 5 frequencies, and the changes increase
systematically with increasing ICP. Statistically significant
changes in DPOAE magnitudes were also present, but for
fewer frequencies and only at higher ICP levels.
Conclusions
This is the first study to measure change in DPOAE
magnitude and angle as a function of ICP. Systematic
trends are present for both magnitude and angle; how-
ever DPOAE angle appears more robust, consistent with
a previous study of DPOAE in patients undergoing LP
and CSF removal. DPOAE may be more reliable in
younger subjects with better hearing than the subjects
evaluated in this study. For future use of DPOAE as a
noninvasive ICP modality, if knowledge of the magni-
tude of ICP change (in mm Hg or kPa) in relation to
change in DPOAE magnitude or angle is required, then
an initial calibration of DPOAE with invasive ICP moni-
toring will be necessary.
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